Osteosarcoma
Showing 51 - 75 of 178
Bone Sarcoma, Osteosarcoma Trial in France (Treatment by regorafenib and best supportive care, Treatment by and best supportive
Recruiting
- Bone Sarcoma
- Osteosarcoma
- Treatment by regorafenib and best supportive care
- Treatment by placebo and best supportive care
-
Besançon, France
- +13 more
May 12, 2022
Pediatric Solid Tumor, Germ Cell Tumor, Retinoblastoma Trial in Seattle (second generation 4-1BB? EGFR806-EGFRt, second
Recruiting
- Pediatric Solid Tumor
- +15 more
- second generation 4-1BBζ EGFR806-EGFRt
- second generation 4-1BBζ EGFR806-EGFRt and a second generation 4 1BBζ CD19-Her2tG
-
Seattle, WashingtonSeattle Children's Hospital
May 2, 2022
Neuroectodermal Tumors, Primitive, Liver Tumors, Osteosarcoma Trial in Los Angeles (N-Acetylcysteine)
Completed
- Neuroectodermal Tumors, Primitive
- +3 more
-
Los Angeles, CaliforniaChildrens Hospital Los Angeles
Apr 28, 2022
Ewing Sarcoma, Neuroblastoma, Rhabdomyosarcoma Trial in Milwaukee (Allogeneic HCT, Donor NK Cell Infusion)
Active, not recruiting
- Ewing Sarcoma
- +4 more
- Allogeneic HCT
- Donor NK Cell Infusion
-
Milwaukee, Wisconsin
- +1 more
Apr 5, 2022
Sarcoma, Bone, Sarcoma, Soft Tissue, Osteosarcoma Trial in Memphis (Diffusion Weighted Magnetic Resonance Imaging)
Active, not recruiting
- Sarcoma, Bone
- +5 more
- Diffusion Weighted Magnetic Resonance Imaging
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Apr 4, 2022
The Prognostic Value of Serum Biomarkers in Osteosarcoma
Completed
- Osteosarcoma
- case series review of clinical data
-
Bologna, BO, ItalyIRCCS Itituto Ortopedico Rizzoli
Mar 25, 2022
Recurrent or Refractory Solid Tumors, Ewing Sarcoma, Rhabdomyosarcoma Trial in United States (MM-398 (Irinotecan Sucrosofate
Recruiting
- Recurrent or Refractory Solid Tumors
- +4 more
- MM-398 (Irinotecan Sucrosofate Liposome Injection) plus cyclophosphamide
-
Cincinnati, Ohio
- +5 more
Mar 17, 2022
Osteosarcoma, Ewing Sarcoma, Rhabdomyosarcoma Trial in Washington (Cryoablation Therapy, Nivolumab, Ipilimumab)
Recruiting
- Osteosarcoma
- +9 more
- Cryoablation Therapy
- +2 more
-
Washington, District of ColumbiaChildren's National Hospital
Mar 21, 2022
Neuroblastoma, Neuroblastoma Recurrent, GD2-positive Solid Tumors Trial in Roma (GD2-CART01)
Recruiting
- Neuroblastoma
- +5 more
- GD2-CART01
-
Roma, ItalyOspedale Pediatrico Bambino Gesù
Mar 9, 2022
Collecting and Storing Samples of Blood and Tumor Tissue From
Active, not recruiting
- Osteosarcoma
- Cytology Specimen Collection Procedure
-
Birmingham, Alabama
- +179 more
Mar 23, 2022
Late Effects, Testicular Germ Cell Tumor Mixed, Non-Metastatic Breast Carcinoma Trial in Lyon (PASCA intervention)
Recruiting
- Late Effects
- +8 more
- PASCA intervention
-
Lyon, FranceCentre Leon Berard
Mar 15, 2022
Osteosarcoma, Tumors, Connective Tissue, Tumors, Connective and Soft Tissue Trial in Moscow (Doxorubicin, Cisplatin,
Recruiting
- Osteosarcoma
- +4 more
- Doxorubicin, Cisplatin, Methotrexate
- Doxorubicin, Cisplatin
-
Moscow, Russian FederationFederal State Budgetary Institution "N.N. Blokhin National Medic
Mar 1, 2022
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Hodgkin Lymphoma Trial in Madison (TCRaß+/CD19+ depleted Haploidentical
Recruiting
- Acute Myeloid Leukemia
- +10 more
- TCRαβ+/CD19+ depleted Haploidentical HSCT
- Zoledronate
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Mar 1, 2022
Solid Tumor, Lymphoma, Osteosarcoma Trial in Orange (Surufatinib in combination with Gemcitabine)
Recruiting
- Solid Tumor
- +5 more
- Surufatinib in combination with Gemcitabine
-
Orange, CaliforniaChildrens Hospital Orange County
Feb 8, 2022
Neuroblastoma, Rhabdomyosarcoma, Ewing Sarcoma Family of Tumors Trial in France (Sampling on blood, bone marrow and
Recruiting
- Neuroblastoma
- +5 more
- Sampling on blood, bone marrow and cerebrospinal fluid
-
Amiens, France
- +29 more
Feb 23, 2022
Pancreatic Cancer, Osteosarcoma, MPNST (Malignant Peripheral Nerve Sheath Tumor) Trial in Santa Monica (DeltaRex-G)
Available
- Pancreatic Cancer
- +6 more
-
Santa Monica, CaliforniaSarcoma Oncology Research Center, LLC
Jan 20, 2022
Survival Outcomes in Patients With Osteosarcoma
Recruiting
- Osteosarcoma
- Prediction model
-
Chengdu, Sichuan, ChinaWest China Hospital, Sichuan University
Jan 15, 2022
Relapsed Pediatric Solid Tumors, Refractory Pediatric Solid Tumors, Rhabdomyosarcoma Trial in Washington, Cincinnati (Magnetic
Active, not recruiting
- Relapsed Pediatric Solid Tumors
- +9 more
- Magnetic Resonance High Intensity Focused Ultrasound
-
Washington, District of Columbia
- +1 more
Jan 21, 2022
ICONIC: Improving Outcomes Through Collaboration in OsteosarComa
Recruiting
- Osteosarcoma
- observational only, no interventions are prescribed in protocol.
-
London, Greater London, United Kingdom
- +17 more
Jan 19, 2022
Pediatric Cancer, Solid Tumors, Rhabdomyosarcoma Trial in Washington (Magnetic resonance high intensity focused ultrasound,
Recruiting
- Pediatric Cancer
- +9 more
- Magnetic resonance high intensity focused ultrasound
- Lyso-thermosensitive liposomal doxorubicin
-
Washington, District of ColumbiaChildren's National Medical Center
Dec 10, 2021
Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma Trial in Providence (Gemcitabine, 9-ING-41,
Withdrawn
- Soft Tissue Sarcoma
- +12 more
- Gemcitabine
- +2 more
-
Providence, Rhode Island
- +1 more
Nov 30, 2021
Pediatric Solid Tumor, Pediatric Lymphoma, Pediatric Brain Tumor Trial in Australia, Canada, United States (CLR 131)
Recruiting
- Pediatric Solid Tumor
- +7 more
- CLR 131
-
Palo Alto, California
- +6 more
Nov 30, 2021